| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs570629701 |
chr1:241585507-241585508 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 2 |
rs5012572 |
chr1:241585523-241585524 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 3 |
rs561082793 |
chr1:241585590-241585591 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 4 |
rs186721532 |
chr1:241585624-241585625 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 5 |
rs76483095 |
chr1:241585661-241585662 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 6 |
rs560106897 |
chr1:241585692-241585693 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 7 |
rs12037737 |
chr1:241585725-241585726 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 8 |
rs57443902 |
chr1:241585731-241585732 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 9 |
rs1539099 |
chr1:241585802-241585803 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 10 |
rs138175512 |
chr1:241585899-241585900 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs115731499 |
chr1:241585904-241585905 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs191323251 |
chr1:241585921-241585922 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs12094986 |
chr1:241585974-241585975 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 14 |
rs77303602 |
chr1:241586003-241586004 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs1539100 |
chr1:241586018-241586019 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 16 |
rs57789558 |
chr1:241586033-241586034 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs371351587 |
chr1:241586063-241586064 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs527544331 |
chr1:241586066-241586067 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs547357470 |
chr1:241586069-241586070 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs570537078 |
chr1:241586100-241586101 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs539448200 |
chr1:241586101-241586102 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs1539101 |
chr1:241586108-241586109 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 23 |
rs527728451 |
chr1:241586143-241586144 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs569776560 |
chr1:241586157-241586158 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs112886680 |
chr1:241586163-241586164 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs116440961 |
chr1:241586185-241586186 |
Weak transcription Bivalent Enhancer Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs572666126 |
chr1:241586224-241586225 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs5782195 |
chr1:241586230-241586231 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs77541746 |
chr1:241586247-241586248 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs1539102 |
chr1:241586280-241586281 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 31 |
rs576954568 |
chr1:241586292-241586293 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs545775029 |
chr1:241586332-241586333 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs562573061 |
chr1:241586336-241586337 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs576058045 |
chr1:241586338-241586339 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs112725506 |
chr1:241586345-241586346 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs1539103 |
chr1:241586376-241586377 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs184412505 |
chr1:241586386-241586387 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs146105390 |
chr1:241586397-241586398 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs188104556 |
chr1:241586425-241586426 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs192713199 |
chr1:241586446-241586447 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs112225840 |
chr1:241586458-241586459 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs185273564 |
chr1:241586461-241586462 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs145931687 |
chr1:241586463-241586464 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs201308917 |
chr1:241586488-241586489 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs569838588 |
chr1:241586515-241586516 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs529355908 |
chr1:241586520-241586521 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs112098876 |
chr1:241586542-241586543 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs55825634 |
chr1:241586557-241586558 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 49 |
rs566291684 |
chr1:241586589-241586590 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs114197882 |
chr1:241586591-241586592 |
Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|